Results 271 to 280 of about 48,512 (351)

The difference in type 2 diabetes care between the National Health Insurance beneficiaries and public assistance recipients in Japan: A retrospective cohort study based on claims data in a municipality

open access: yesJournal of Diabetes Investigation, EarlyView.
We examined the differences in type 2 diabetes care between public assistance recipients and National Health Insurance beneficiaries in Japan by using claims data from a municipality. Public assistance might improve diabetes care process, but not fully health outcomes.
Takuya Yamaoka   +4 more
wiley   +1 more source

Predictors of glycemic control with imeglimin for type 2 diabetes: Results of machine learning analyses using clinical trial data

open access: yesJournal of Diabetes Investigation, EarlyView.
Identifying patient characteristics predictive of treatment response is crucial for optimizing type 2 diabetes outcomes. Using data from three phase 2/3 imeglimin trials in Japan, this analysis applied machine learning to determine characteristics associated with HbA1c improvement.
Katsuhiko Hagi   +4 more
wiley   +1 more source

Analysis of glycemic index, glycemic load and acceptability of enteral formulas based on tempeh flour and jicama flour as innovations for hyperglycemia patients

open access: gold, 2020
Lono Wijayanti   +6 more
openalex   +1 more source

COVID‐19 and diabetic ketoacidosis: National outcomes, predictors, and resource utilization in the United States

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Background The impact of COVID‐19 infection on diabetic ketoacidosis (DKA) outcomes remains incompletely characterized at a national level. Methods We analyzed adult DKA hospitalizations in the United States from the 2020–2021 National Inpatient Sample.
Jia Ee Chia   +4 more
wiley   +1 more source

High Dietary Glycemic Load is Associated With Increased Risk of Colon Cancer

open access: green, 2014
Svetlana Zelenskiy   +3 more
openalex   +1 more source

Dietary glycemic index, glycemic load, and the risk of breast cancer in an Italian prospective cohort study [PDF]

open access: bronze, 2007
Sabina Sieri   +10 more
openalex   +1 more source

Linderalactone mitigates diabetic renal injury by inhibiting macrophage inflammation via the Dectin1/Syk/CARD9/IRF5/NF‐κB pathway

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Background Inflammation plays an essential role in the pathogenesis of diabetic nephropathy (DN). Linderalactone (LNL), as a natural sesquiterpene lactone, has been discovered to have anti‐inflammatory activation. However, the effects of linderalactone on diabetes‐associated renal damage remain unclear.
Hao Chen   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy